These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 21719985)

  • 1. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T
    Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
    Nishida A; Ito M
    Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bisphosphonate therapy for osteoporosis and bone strength].
    Kishimoto H
    Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis in patients with diabetes mellitus].
    Yamauchi M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():526-30. PubMed ID: 18161160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone quality].
    Ito M
    Nihon Rinsho; 2009 May; 67(5):921-5. PubMed ID: 19432110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of osteoporosis in men].
    Hosoi T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():495-8. PubMed ID: 18161155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M; Vierkoetter KR
    Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
    Kishimoto H
    Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary osteoporosis--its diagnosis and treatment].
    Inaba M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():485-9. PubMed ID: 18161153
    [No Abstract]   [Full Text] [Related]  

  • 15. Who will benefit from antiresorptive treatment (bisphosphonates)?
    Papapoulos SE
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New development in bisphosphonate treatment. Effect of bisphosphonate on structural property].
    Ito M
    Clin Calcium; 2009 Jan; 19(1):20-9. PubMed ID: 19122261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy.
    Lim JS; Jin SH; Kim SB; Lee JI
    J Clin Gastroenterol; 2012 Sep; 46(8):669-74. PubMed ID: 22504799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.